Skip to site menu Skip to page content

Daily Newsletter

28 August 2023

Daily Newsletter

28 August 2023

TachyHealth, Zayed University to fight healthcare fraud with AI

This project is supported by a RIF grant, with its team headed by Zayed University principal investigator Dr. Dina Tbaishat.

August 28 2023

AI-driven health tech firm TachyHealth has joined hands with Abu Dhabi’s Zayed University on a two-year project, which aims to address healthcare abuse, reported Zawya.

The partners aim to combat healthcare fraud with Graph Neural Networks (GNNs).

They will work on creating GNN algorithms for identifying fraudulent transactions in healthcare systems.

This project, named Fraud detection in medical claims using Graph Neural Networks, is being supported by a AED300,000 ($81,677) Research Innovation Fund (RIF) grant.

Its team is being headed by Zayed University principal investigator Dr. Dina Tbaishat. 

Zayed University associate professor Dr. Mohamed Amril Nazir said: “Closer collaboration with the private sector produces research which aligns with national and international agendas, and adds value to businesses and governments.

“This is a key component of Zayed University’s approach to research.” 

In addition, the collaboration will develop a visual decision support system for deploying these algorithms as real-world solutions.

This is expected to reduce fraud, prevent abuse of medical services, and lessen the workload on institutions.

TachyHealth CEO Dr. Osama AbouElkhir said: “The number of claims made by beneficiaries has risen rapidly because of fraudulent billing, and detecting fraudulent transactions is difficult owing to various complexities.

“This project seeks to address healthcare fraud and abuse using AI, which will save money and improve patient care.”

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close